Literature DB >> 11963837

Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation: mediation by nitric oxide system.

Yves Garnier1, Johannes Middelanis, Arne Jensen, Richard Berger.   

Abstract

OBJECTIVE: We investigated the effects of magnesium on metabolic disturbances in hippocampal slices prepared from fetal guinea pigs after oxygen-glucose deprivation (OGD).
METHODS: Metabolic disturbances were assessed by measuring changes in energy metabolism and protein synthesis. In addition we determined cyclic guanosine monophosphate (cGMP) concentrations in the slices after OGD, as a measure of nitric oxide (NO) production, to clarify whether a possible neuroprotective effect of magnesium is mediated in part through the NO system.
RESULTS: Twelve hours after oxygen-glucose deprivation, adenosine triphosphate (ATP) concentration and protein synthesis in the hippocampal slices were significantly reduced depending on the severity of OGD. A higher magnesium concentration in the incubation medium from 1.3 mM to 3.9 mM 2 hours before OGD significantly improved the recovery of ATP and protein synthesis, whereas treatment after OGD was ineffective. The cGMP concentrations increased dramatically in hippocampal slices 10 minutes after OGD, indicating a significant increase in NO production. When the concentration of magnesium in the artificial cerebrospinal fluid was increased 2 hours before OGD the rise in tissue levels of cGMP was considerably reduced. Again, treatment after OGD had no effect.
CONCLUSION: We conclude that increasing magnesium concentration in the artificial cerebrospinal fluid before OGD alleviated metabolic disturbances in hippocampal slices from mature fetal guinea pigs, whereas treatment after OGD had no effect. This neuroprotective property of magnesium might be mediated in part through the inhibition of NO production shortly after OGD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11963837     DOI: 10.1016/s1071-5576(01)00161-7

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  7 in total

1.  Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

2.  The effect of antenatal magnesium sulfate on intraventricular hemorrhage in premature infants: a systematic review and meta-analysis.

Authors:  Yousef Moradi; Rozhin Khateri; Ladan Haghighi; Shoaib Dehghani; Shiva Mansouri Hanis; Mehrdad Valipour; Zahra Najmi; Zahra Fathollahy; Meisam Allahmoradi; Kamyar Mansori
Journal:  Obstet Gynecol Sci       Date:  2020-06-24

3.  Effects of magnesium sulfate administration during hypoxia on Ca(2+) influx and IP(3) receptor modification in cerebral cortical neuronal nuclei of newborn piglets.

Authors:  Ahmed G Mami; Juan Ballesteros; Om P Mishra; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

4.  Effects of magnesium sulfate administration during hypoxia on CaM kinase IV and protein tyrosine kinase activities in the cerebral cortex of newborn piglets.

Authors:  Ahmed G Mami; Juan R Ballesteros; Karen I Fritz; Joanna Kubin; Om P Mishra; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

Review 5.  Neuroprotection in preterm infants.

Authors:  R Berger; S Söder
Journal:  Biomed Res Int       Date:  2015-01-11       Impact factor: 3.411

6.  Upregulation of miR-376c-3p alleviates oxygen-glucose deprivation-induced cell injury by targeting ING5.

Authors:  Heng Zhang; Jie Zhou; Mingxia Zhang; Yanjie Yi; Bing He
Journal:  Cell Mol Biol Lett       Date:  2019-12-04       Impact factor: 5.787

7.  A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection: What Have We Learnt From the Past Decade?

Authors:  Robert Galinsky; Justin M Dean; Ingran Lingam; Nicola J Robertson; Carina Mallard; Laura Bennet; Alistair J Gunn
Journal:  Front Neurol       Date:  2020-05-27       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.